Medicine and Dentistry
Cystic Fibrosis
50%
Antibiotic Therapy
50%
Bronchiectasis
50%
Chronic Obstructive Pulmonary Disease
50%
Asthma
50%
Antibiotics
50%
Open-Label Trial
50%
Chronic Lung Disease
50%
Pseudomonas aeruginosa
50%
Biological Therapy
50%
Severe Asthma
50%
Work Capacity
50%
Silo-Filler's Disease
20%
Infection
20%
Disability Pension
11%
Lower Respiratory Tract
10%
Beta Lactam
10%
Ciprofloxacin
10%
Prednisolone
10%
Cohabitation
5%
Cohort Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Biological Product
50%
Diseases
50%
Remission
23%
Disease Duration
10%
Pseudomonas Infection
10%
Cohort Study
8%
Prevalence
7%
Comorbidity
7%
Keyphrases
Non-cystic Fibrosis Bronchiectasis
50%
Targeted Antibiotic
50%
Targeted Antibiotic Therapy
50%
Respiratory Tract Samples
16%
Pseudomonas Aeruginosa Infection
16%
Co-primary Endpoints
16%
Reduced Morbidity
16%
Asthma Impact
5%
Earned Income
5%
